Concepedia

Rochelle Bagatell

RB

Statistics

Publications

95

Citations

6.3K

H-Index

44

Active since

1999

Affiliations

Children's Hospital of Philadelphia(Current)

University of Pennsylvania

Children's Oncology Group

Seattle Children's Hospital

Dana-Farber/Boston Children's Cancer and Blood Disorders Center

Rochelle Bagatell is an author at Children's Hospital of Philadelphia specializing in oncology, medicine, and pediatric oncology.

Publications per year

1999–2025

95

Publications

95

Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group

Meredith S. Irwin, Arlene Naranjo, Fan F. Zhang et al. · Journal of Clinical Oncology · 2021 · 474 citations · Full text

Medicine, Oncology, Pediatrics +17

Combination of Trastuzumab and Tanespimycin (17-AAG, KOS-953) Is Safe and Active in Trastuzumab-Refractory HER-2–Overexpressing Breast Cancer: A Phase I Dose-Escalation Study

Shanu Modi, Alison Stopeck, Michael S. Gordon et al. · Journal of Clinical Oncology · 2007 · 334 citations

Medicine, Pharmacology, Pharmacotherapy +15

Altered Hsp90 function in cancer: A unique therapeutic opportunity

Rochelle Bagatell, Luke Whitesell · Molecular Cancer Therapeutics · 2004 · 304 citations · Full text

Medicine, Oncology, Pharmacology +16

Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of hsp90-binding agents.

Rochelle Bagatell, Gillian Paine-Murrieta, Charles W. Taylor et al. · PubMed · 2000 · 273 citations

Medicine, Oncology, Pharmacology +15

Irinotecan–temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial

Rajen Mody, Arlene Naranjo, Collin Van Ryn et al. · The Lancet Oncology · 2017 · 273 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

1–5 of 95